The amplified peptidome: the new treasure chest of candidate biomarkers.

[1]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[2]  E. Diamandis.  Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? , 2003, Clinical chemistry.

[3]  A. Olshen,et al.  Differential exoprotease activities confer tumor-specific serum peptidome patterns. , 2005, The Journal of clinical investigation.

[4]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[5]  R. Bast,et al.  Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[6]  M. Ferrari,et al.  Clinical proteomics: Written in blood , 2003, Nature.

[7]  E. Petricoin,et al.  Serum proteomic patterns for detection of prostate cancer. , 2002, Journal of the National Cancer Institute.

[8]  Steven J Skates,et al.  Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Schellhammer,et al.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.

[10]  E. Petricoin,et al.  Analysis of albumin-associated peptides and proteins from ovarian cancer patients. , 2005, Clinical chemistry.

[11]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[12]  Young Y. Wang,et al.  A simple affinity spin tube filter method for removing high‐abundant common proteins or enriching low‐abundant biomarkers for serum proteomic analysis , 2003, Proteomics.

[13]  E. Petricoin,et al.  A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. , 2005, Arthritis and rheumatism.

[14]  A. Vlahou,et al.  A novel approach toward development of a rapid blood test for breast cancer. , 2003, Clinical breast cancer.

[15]  T. M. Thomas,et al.  Depletion of the highly abundant protein albumin from human plasma using the Gradiflow , 2003, Proteomics.

[16]  Emanuel F Petricoin,et al.  Lessons from Kitty Hawk: From feasibility to routine clinical use for the field of proteomic pattern diagnostics , 2004, Proteomics.

[17]  T. Zhukov,et al.  Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. , 2003, Lung cancer.

[18]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[19]  Min Zhan,et al.  A data review and re-assessment of ovarian cancer serum proteomic profiling , 2003, BMC Bioinformatics.

[20]  N. Anderson,et al.  Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome , 2003, Proteomics.

[21]  B. Hitt,et al.  Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. , 2005, Endocrine-related cancer.

[22]  P. Schellhammer,et al.  Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. , 2002, Clinical chemistry.

[23]  T. Yip,et al.  Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. , 2003, Clinical chemistry.

[24]  Emanuel F. Petricoin,et al.  Biomarker Amplification by Serum Carrier Protein Binding , 2004, Disease markers.

[25]  Emanuel F Petricoin,et al.  Importance of communication between producers and consumers of publicly available experimental data. , 2005, Journal of the National Cancer Institute.

[26]  E. Petricoin,et al.  An investigation into the human serum “interactome” , 2004, Electrophoresis.

[27]  K. Lillemoe,et al.  Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. , 2002, Cancer research.

[28]  P. Malfertheiner,et al.  Identification of gastric cancer patients by serum protein profiling. , 2004, Journal of proteome research.

[29]  T. Kang,et al.  Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons , 2003, Proteomics.

[30]  David A Bennett,et al.  High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. , 2005, Clinical chemistry.

[31]  E. Holland,et al.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.

[32]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.